Bloomberg News
Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos

Generic Ozempic to Upend Global Weight-Loss Drug Market

Posted

February 8, 2026

Views

2,170

Likes

28

Comments

1

Engagement

1.34%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Shares of Novo Nordisk were down Thursday morning after Hims & Hers introduced a compounded version of its Wegovy pill.

The dip came two days after Novo predicted its sales could drop as much as 13% this year as the company factors in competition from generic drugs that could crop up as its patents expire around the world.

#weightloss #business #us

----------

Like this video? Subscribe

Bloomberg News is the first word in business news. Visit bloomberg.com for the latest on global business, markets and more.

Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months

Bloomberg on YouTube:

Connect with us on social:

Guests & Subjects Covered

Novo NordiskSubscribe Bloomberg NewsYouTube Connect

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Generic Ozempic to Upend Global Weight-Loss Drug Market · Bloomberg News · Sentinel